Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener's granulomatosis as compared to rheumatoid arthritis and chronic rhinosinusitis with nasal polyps

Clinical and Experimental Rheumatology

Volumn 28, Issue 1 SUPPL. 57, 2010, Pages

  Laudien, Martin ^a   Gadola, Stephan D ^b   Podschun, Rainer ^c   Hedderich, Jürgen ^c   Paulsen, Jens ^d   Relnhold Keller, Eva ^e   Csernok, Elena ^e   Ambrosch, Petra ^a   Hellmich, Bernhard ^f   Moosig, Frank ^e   Gross, Wolfgang L ^e   Sahly, Hany ^c   Lamprecht, Peter ^e  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d St Marienhospital Vechta   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f Kreiskrankenhaus Plochingen ^*  (Germany)

Author keywords

Activity; Endoscopy; Relapse; Staphylococcus aureus; Wegener's granulomatosis

Indexed keywords

COTRIMOXAZOLE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; ENDOSCOPY; HUMAN; MAJOR CLINICAL STUDY; MICROBIAL ACTIVITY; NASAL COLONISATION; NOSE POLYP; PRIORITY JOURNAL; RELAPSE; RHEUMATOID ARTHRITIS; RHINOSINUSITIS; SEROLOGY; STAPHYLOCOCCUS AUREUS; UPPER RESPIRATORY TRACT; WEGENER GRANULOMATOSIS; BACTERIUM CARRIER; CHRONIC RHINOSINUSITIS; DISEASE ACTIVITY; NONHUMAN; RISK FACTOR; VERY ELDERLY; BLOOD; CHRONIC DISEASE; HEALTH CARE PERSONNEL; HETEROZYGOTE; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NOSE MUCOSA; RECURRENT DISEASE; RHINITIS; SINUSITIS; STAPHYLOCOCCUS INFECTION; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ARTHRITIS, RHEUMATOID; CARRIER STATE; CHRONIC DISEASE; HEALTH PERSONNEL; HUMANS; INCIDENCE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; RECURRENCE; RHINITIS; SINUSITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; WEGENER GRANULOMATOSIS; YOUNG ADULT;

EID: 77954619161     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. BACON PA: The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med 2005; 352: 330-2.
2. HOFFMAN GS, KERR GS, LEAVITT RY et al.: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
3. REINHOLD-KELLER E, BEUGE N, LATZA U, DE GROOT K, RUDERT H, NOLLE B, HELLER M, GROSS WL: An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000: 43: 1021-32.
4. STEGEMAN CA, TERVAERT JW, SLUITER WJ, MANSON W, DE JONG PE, KALLENBERG CG: Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994; 120: 12-7.
5. STEGEMAN CA, TERVAERT JW, DE JONG PE, KALLENBERG CG: Trimethoprim- sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996; 335: 16-20.
6. POPA E, STEGEMAN CA, ABDULAHAD WH et al.: Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis. Rheumatology (Oxford) 2007; 46: 1029-33.
7. WERTHEIM HF, MELLES DC, VOS MC et al.: The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5: 751-62.
8. SWIDSINSKI A, LADHOFF A, PERNTHALER A et al.: Mucosal flora in inflammatory bowel disease. Gastroenterology 2002; 122: 44-54.
9. AVCIN T, CANOVA M, GUILPAIN P et al.: Infections, connective tissue diseases and vasculitis. Clin Exp Rheumatol 2008; 26: S18-S26.
10. ULLRICH S, GUSTKE H, LAMPRECHT P et al.: Severely impaired respiratory ciliar function in Wegener's Granulomatosis. Ann Rheum Dis 2009; 68: 1067-71.
11. PENDERGRAFT WF 3RD, PRESTON GA, SHAH RR et al.: Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004; 10: 72-9.
12. JENNETTE JC, FALK RJ, ANDRASSY K et al.: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
13. LEAVITT RY, FAUCI AS, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
14. DE REMEE RA, MCDONALD TJ, HARRISON E JR, COLES DT: Wegener's granulomatosis. Anatomic correlates, a proposed classification. Mayo Clin Proc 1976; 51: 777-81.
15. HELLMICH B, FLOSSMANN O, GROSS WL et al.: EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007; 66: 605-17.
16. PAULSEN JI, RUDERT H: [Manifestations of primary vasculitis in the ENT region]. Z Rheumatol 2001; 60: 219-25.
17. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
18. BENNINGER MS, FERGUSON BJ, HADLEY JA et al.: Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol. Head Neck Surg 2003; 129: S1-32.
19. DE REMEE RA: The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision? Arthritis Rheum 1988; 31: 1068-74.
20. KALLENBERG CG, STEGEMAN CA, TERVAERT JW: Staphylococcus aureus, trimethoprim-sulfamethoxazole, and Wegener's granulomatosis. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 253-55.
21. POPA ER, TERVAERT JW: The relation between Staphylococcus aureus and Wegener's granulomatosis: current knowledge and future directions. Intern Med 2003; 42: 771-80.
22. VAN PUTTEN JW, VAN HAREN EH, LAMMERS JW: Association between Wegener's granulomatosis and Staphylococcus aureus infection? Eur Respir J 1996; 9: 1955-7.
23. FAUCI AS, HAYNES BF, KATZ P, WOLFF SM: Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 76-85.
24. PINCHING AJ, REES AJ, PUSSELL BA, LOCKWOOD CM, MITCHISON RS, PETERS DK: Relapses in Wegener's granulomatosis: the role of infection. Br Med J 1980; 281: 836-8.
25. MAYET WJ, MARKER-HERMANN E, SCHLAAK J, MEYER ZUM BUSCHENFELDE KH: Irregular cytokine pattern of CD4+ T lymphocytes in response to Staphylococcus aureus in patients with Wegener's granulomatosis. Scand J Immunol 1999; 49: 585-94.
26. POPA ER, STEGEMAN C, KALLENBERG CG, TERVAERT JW: Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res 2002; 4: 77-79.
27. BISCHOFF WE, WALLIS ML, TUCKER KB, REBOUSSIN BA, SHERERTZ RJ: Staphylococcus aureus nasal carriage in a student community: prevalence, clonal relationships, and risk factors. Infect Control Hasp Epidemiol 2004; 25: 485-91.
28. DAMM M, QUANTE G, JURK T, SAUER JA: Nasal colonization with Staphylococcus aureus is not associated with the severity of symptoms or the extent of the disease in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2004; 131: 200-6.
29. LOWY FD: Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
30. th European Congress of Clinical Microbiology and Infectious Diseases. Eur J Clin Microbiol Infect Dis 2005; 24: 145-8.
31. BASSETTI S, WASMER S, HASLER P et al.: Staphylococcus aureus in patients with rheumatoid arthritis under conventional and anti-tumor necrosis factor-alpha treatment. J Rheumatol 2005; 32: 2125-9.
32. LUCET JC, CHEVRET S, DURAND-ZALESKI I, CHASTANG C, REGNIER B: Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med 2003; 163: 181-8.
33. CLEMENT S, VAUDAUX P, FRANCOIS P et al.: Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis 2005; 192: 1023-8.
34. GEVAERT P, HOLTAPPELS G, JOHANSSON SG, CUVELIER C, CAUWENBERGE P, BACHERT C: Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 2005; 60: 71-9.
35. BERNSTEIN JM: Mucosal immunology of the upper respiratory tract. Respiration 1992; 59 (Suppl. 3): 3-13.
36. ISRAEL HL: Sulfamethoxazole-trimethoprim therapy for Wegener's granulomatosis. Arch Intern Med 1988; 148, 2293-5.
37. RASMUSSEN N, PETERSEN J, REMVIG L, ANDERSEN V: Treatment of Wegener's granulomatosis with trimethoprim-sulfamethoxazole. APMIS 1990; Suppl 19: 61-62.
38. RUSTERHOLZ D, SCHLEGEL C: [Infectious aspects of Wegener's granulomatosis]. Schweiz Med Wochenschr 2000; (Suppl. 125): 41S-43S.
39. DE GROOT K, REINHOLD-KELLER E, TATSIS E et al.: Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 1996; 39: 2052-61.
40. REINHOLD-KELLER E, DE GROOT K, RUDERT H, NOLLE B, HELLER M, GROSS WL: Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease. QJM 1996; 89: 15-23.